The electrocardiographically quantified QRS duration measures ventricular depolarization and conduction. QRS prolongation has been associated with poor heart failure prognosis and cardiovascular mortality, including sudden death. While previous genome-wide association studies (GWAS) have identified 32 QRS SNPs across 26 loci among European, African, and Asian-descent populations, the genetics of QRS among Hispanics/Latinos has not been previously explored.
We performed a GWAS of QRS duration among Hispanic/Latino ancestry populations (n = 15,124) from four studies using 1000 Genomes imputed genotype data (adjusted for age, sex, global ancestry, clinical and study-specific covariates). Study-specific results were combined using fixed-effects, inverse variance-weighted meta-analysis.
We identified six loci associated with QRS (P<5x10-8), including two novel loci: MYOCD, a nuclear protein expressed in the heart, and SYT1, an integral membrane protein. The top SNP in the MYOCD locus, intronic SNP rs16946539, was found in Hispanics/Latinos with a minor allele frequency (MAF) of 0.04, but is monomorphic in European and African descent populations. The most significant QRS duration association was with intronic SNP rs3922344 (P = 1.19x10-24) in SCN5A/SCN10A. Three other previously identified loci, CDKN1A, VTI1A, and HAND1, also exceeded the GWAS significance threshold among Hispanics/Latinos. A total of 27 of 32 previously identified QRS duration SNPs were shown to generalize in Hispanics/Latinos.
Citation: Swenson BR, Louie T, Lin HJ, Méndez-Giráldez R, Below JE, Laurie CC, et al. (2019) GWAS of QRS duration identifies new loci specific to Hispanic/Latino populations. PLoS ONE 14(6): e0217796. https://doi.org/10.1371/journal.pone.0217796
Editor: Amanda Ewart Toland, Ohio State University Wexner Medical Center, UNITED STATES
Received: January 30, 2019; Accepted: May 17, 2019; Published: June 28, 2019
This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Data Availability: The full meta-Analysis results are available from the dbGAP database (https://www.ncbi.nlm.nih.gov/gap) with accession number phs000930.
Funding: JEB is supported by NIH (R01HL142302). AAS is supported by NHLBI training grants (T32HL7055 and T32HL07779). DD is supported by NIH (R01HL124935; T32 HL139439) and NHLBI (HL092217). NAB is supported by NIH/NHLBI K23 HL136853 and the Katz Foundation. CLA is supported by NIH (T32HL007055). NS is supported by the NIH (HL116747, HL111089); and the Laughlin family. Additionally this work is indirectly supported by the funding received by each cohort study which contributed data to the analysis: Hispanic Community Health Study/Study of Latinos (HCHS/SOL): The baseline examination of HCHS/SOL was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), San Diego State University (N01-HC65237), and the Brigham and Women’s Hospital (HHSN268201300024C). The following Institutes/Centers/Offices contributed to the first phase of HCHS/SOL through a transfer of funds to the National Hearth Lung and Blood Institute (NHLBI): National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, NIH Institution-Office of Dietary Supplements. The Genetic Analysis Center at University of Washington was supported by NHLBI and National Institute of Dental and Craniofacial Research contracts (HHSN268201300005C AM03 and MOD03). Genotyping efforts were supported by NHLBI HSN 26220/20054C, NCATS CTSI grant UL1TR000124, and NIDDK Diabetes Research Center (DRC) grant DK063491. Multi-Ethnic Study of Atherosclerosis (MESA): MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, UL1-TR-001881, and DK063491. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Starr County Study: This work was supported in part by grants DK073541, DK020595, AI085014, DK085501, and HL102830 from the National Institutes of Health and funds from the University of Texas Health Science Center at Houston. Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is funded through a federal contract from the National Institutes of Health (NIH) to The Johns Hopkins University, contract number HHSN268200782096C. Women’s Health Initiative: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts: HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: Dr. Nalls consults for Illumina Inc., the Michael J. Fox Foundation and University of California Healthcare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
The duration of the QRS complex on a resting, standard 12-lead electrocardiogram (ECG) represents the electrical depolarization of the ventricles as an impulse travels through the cardiac conduction system and the ventricular myocardium. Delay in cardiac ventricular conduction results in increased QRS durations, and has been shown to predict heart failure prognosis,[1, 2] sudden death, and cardiovascular (CV) mortality in patients with and without left ventricular dysfunction, independent of traditional CV risk factors. In turn, shortening of the QRS duration with the use of cardiac-resynchronization therapy (CRT) has been shown to decrease heart-failure related events in patients with QRS prolongation.
To date, heritability estimates of QRS duration have varied, with up to ~40% heritability found in more recent studies.[6–9] While previous genome-wide association studies have focused predominantly on European populations,[10–12] there have been several smaller studies of Asian,[13–15] Pacific Islander, and African American populations.[17, 18] Collectively, these GWAS analyses have identified 32 SNPs across 26 loci associated with QRS duration. These loci harbor ion channel and transcription factor genes involved in cardiac conduction, including SCN5A, SCN10A, TBX3, TBX5, TBX20, and HAND1.[10–14, 16–18] To our knowledge, there has been no GWAS performed to study the genetics of QRS duration in Hispanic/Latino ancestry populations. We therefore performed a GWAS of QRS duration in four Hispanic/Latino study populations: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the Multi-Ethnic Study of Atherosclerosis (MESA), the Starr County Study (Starr), and the Women’s Health Initiative (WHI).
Our GWAS included 15,124 Hispanic/Latino individuals from four contributing cohorts. Baseline characteristics varied substantially across the four cohorts. For example, WHI is a study of women only. The average age of the participants across the four cohorts ranged from 45 to 61 years. The prevalence of hypertension and diabetes across the four cohorts ranged from 26% to 42% for hypertension and 8% to 46% for diabetes (S1 Table).
Genome-wide association analysis
Following quality control (see Materials and Methods), individual studies contributed between 5.8 M and 20.2 M individual SNPs, yielding 21.1 M combined, unique SNPs overall. Neither the individual studies (λ range = 0.96–1.03) nor the combined meta-analysis (λ = 1.03) exhibited evidence of test-statistic inflation (S1 and S2 Figs). SNPs in six loci exceeded the genome-wide threshold for significance (Table 1, Fig 1). Two of the loci (MYOCD and SYT1) were novel, whereas the remaining four (SCN5A-SCN10A, HAND1, CDKN1A, and VTI1A) were previously identified in other ethnic groups. There was no evidence of heterogeneity (Cochran’s Q test P-value>0.05, S2 Table), and effect direction was consistent across all contributing studies for all index SNPs (S3 Fig). All index SNPs were either directly genotyped or were imputed with high quality (S3 Table).
Manhattan plot showing the association of SNPs with QRS duration in the GWAS meta-analysis containing 15,124 individuals of Hispanic/Latino ethnicity. The horizontal line represents the genome-wide significance threshold of (P = 5E-08). SNPs mapping to 6 loci exceeded the GWAS threshold for significance.
The meta-analysis identified two novel loci (MYOCD and SYT1) associated with QRS duration. The index SNP (rs16946539) in MYOCD (myocardin, a nuclear protein found in cardiac and smooth muscle), as well as the only SNP (rs139859815) in high LD (r2>0.5) with it, are monomorphic in the European-descent and African-descent 1000 Genomes super populations (S4 Table).
The second novel locus was on chromosome 12 near SYT1 (synaptotagmin-1), an integral membrane protein of synaptic vesicles that responds to calcium signaling. The index SNP in SYT1 (rs4842438) was examined in both European and African ancestry GWAS efforts, but failed to reach nominal significance (P>0.05; Fig 2). Indeed, the effect size of rs4842438 in Hispanics/Latinos (beta = 1.04 ms) is statistically larger than in European-descent (beta = 0.13 ms) and African-descent (beta = 0.00 ms) individuals (P for difference = 5.69x10-5 and 8.65x10-6, respectively, Fig 2, S5–S7 Tables). Moreover, the broad LD pattern seen in Hispanics/Latinos is entirely absent in Europeans and African Americans (S4E Fig). The lack of associations among European and African descent individuals is not explained by lack of power from a smaller sample size or lower MAF (European MAF = 0.06; African MAF = 0.20; Hispanic/Latino MAF = 0.07).
Comparison of effect sizes and 95% confidence intervals for the 9 index SNPs that were genome-wide significant in the Hispanic/Latino QRS duration GWAS, and the effect sizes for corresponding SNPs in the European and African American GWAS. SNP rs10428132 was not directly measured in the European or African American studies, but instead a SNP in perfect LD (r2 = 1) was used (rs6800541). Other SNPs that were not directly measured in Europeans or African Americans are not presented (rs62241190, rs9856387, rs3176326, and rs16946539). * Refers to SNPs where the difference in effect size between two ethnic groups was significant at the Bonferroni corrected P-value. Two SNPs showed larger effects in Hispanics/Latinos than in European-descent individuals: rs3922844 in SCN5A and rs4842438 in SYT1. See S7 Table for additional details.
The most significant association with QRS duration was found in chromosome region 3p22 (rs3922844) at locus 1, bridging SCN5A and SCN10A, two adjacent cardiac sodium-channel genes (Fig 3). This SNP had previously been found to be genome-wide significant among European and African American descent individuals (S5 and S6 Tables). Similar to our findings in Hispanics/Latinos, rs3922844 is the most significantly associated QRS SNP in African Americans (Fig 3). In contrast, among European-descent individuals, the strongest SNP association (rs1601957) resides with an intron of the SCN10A gene. The effect size of rs3922844 in Hispanics/Latinos is statistically larger than in Europeans (1.03 ms vs 0.56 ms decrease in QRS duration, respectively, P for difference = 5.8x10-5), and is closer to the effect size seen among African Americans (0.94 ms, Fig 3 and S5–S7 Tables). Conditional analyses at the SCN5A-SCN10A locus among Hispanics/Latinos revealed three additional independent genome-wide significant secondary signals (Table 1). Two of the secondary index SNPs (rs62241190 and rs9856387) were not tested in either the European or African American GWAS, because those analyses were based on HapMap rather than 1000 Genomes imputation. There are no SNPs in these two populations that are in high LD (r2>0.75) with rs62241190 and rs9856387. Therefore, whether these SNPs are also significantly associated with QRS duration among non-Hispanic/Latino groups is unknown.
A (top-left)–Hispanic/Latino GWAS. B (top right)–European GWAS. C (bottom left)–African American GWAS. Plots created with LocusZoom software. The most significant SNP identified in the Hispanic Latino and African American GWAS was rs3922844 in SCN5A. The most significant SNP in the European GWAS was rs6801957 in SCN10A.
Additional Hispanic/Latino associations in known loci.
Three additional previously discovered SNP-QRS associations were also found in Hispanics/Latinos. These include intronic SNPs within CDKN1A and VTI1A, and an intergenic SNP near HAND1. While the Hispanic/Latino index SNP in CDKN1A (rs3176326) was not directly evaluated in the European or African American GWAS, it was in high LD with a SNP that had been found to be highly significant in the previous European ancestry GWAS (r2 = 0.71 with rs9462210). Interestingly, a conditional analysis of the CDKN1A locus revealed a suggestive secondary signal located in an intron of SPRK1 approximately 1 Mb upstream from the primary CDKN1A signal (rs2395642, P = 4.58x10-6 in conditional analyses; Table 1 and S4C Fig). The index SNP in VTI1A (rs7906312) is a novel SNP within a known locus, but it is not in high LD with the previously known SNP associated with QRS duration in Europeans (S5 Table and S4D Fig). Findings for HAND1 (rs13165478) show that five SNPs in the region (all in very high LD with each other) were significantly associated with QRS duration in this 1000 Genomes imputation analysis. No other SNPs had near significant associations. This same haplotype was also identified as significant among European descent individuals (S4B Fig).
Generalization of previously known SNPs to Hispanics/Latinos.
We examined 32 index SNPs from published GWAS analyses (27 European,1 African-American, 2 East Asian, and 2 from a meta-analysis of the European and African American GWAS results) for association with QRS duration among Hispanics/Latinos[11, 13, 18] (S8 Table, Fig 4). Of the 32 previously identified independent SNPs, 27 generalized in Hispanics/Latinos (r-value <0.05). These included 26 of the 27 SNPs from the European GWAS, with rs1362212 as the exception (S8 Table).
Comparison of effect sizes and 95% confidence intervals for 28 previously discovered SNPs for QRS duration across European, Hispanic/Latino, and African American GWAS results. Findings are largely similar across ethnic groups. * Refers to SNPs where the difference in effect size between two ethnic groups was significant at the Bonferroni corrected P-value. See S7 Table for additional details.
Effect size comparisons.
We then the effect sizes of the independent index SNPs identified in Hispanic/Latino, European descent, and African descent populations (using the current analysis for Hispanic/Latinos, and published meta-analyses for European and African descent individuals; Figs 2 and 4). Not all Hispanic/Latino SNPs were available in European and African-descent individuals, due to differences in imputation sets (HapMap imputation in those of European and African descent versus 1000 genomes imputation in the current analysis). Hence, there are missing European and African-descent data for 4 SNPs, because 3 had no proxy SNP in high LD (r2>0.9) with the index Hispanic/Latino SNP, and one was monomorphic in European and African-descent populations. After Bonferroni correction, 4 of the 29 independent SNPs showed evidence of significant differences in genotype-phenotype effect sizes (Figs 2 and 4, S7 Table).
Cross phenotype analyses
The 9 index SNPs identified in the Hispanic/Latino QRS duration GWAS were also examined for their association with other ECG phenotypes: QT duration, PR duration, heart rate, and SDNN (the standard deviation of normal to normal R-R intervals, a measure of heart rate variability, Table 2, S9 Table). The 4 SNPs in the SCN5A-SCN10A locus were genome-wide significantly associated with both QT and PR interval duration. SNPs that prolong the QRS interval also prolong the PR interval, but conversely shorten the QT interval. This pattern was also observed in the CDKN1A locus. The index SNPs met the Bonferroni corrected significance level for QT duration, but fell just short of significance for PR duration (P = 1.44E-03). Intriguingly, the novel MYOCD locus was significantly associated with PR duration at the Bonferroni corrected significance level, with the SNP that prolongs QRS duration but shortens PR duration. None of the QRS index SNPs were significantly associated with heart rate or SDNN.
Comparison of the effect size and significance level of QRS prolonging index SNPs with QT and PR duration in Hispanics/Latinos. There was no association of QRS SNPs with heart rate or heart rate variability (SDNN). Only significant results (P<0.05) are shown.
The function of all 9 index SNPs was investigated using the HaploReg 4.1 web server. Functional information was obtained for 3 loci: SCN5A-SCN10A, CDKN1A, and MYOCD. SNPs in CDKN1A showed evidence for activating transcription in heart tissues, including fetal heart tissue, the right atrium, the right ventricle, and the left ventricle. SCN5A-SCN10A and MYOCD SNPs were identified as possible enhancers of transcription in the same heart tissues (S10 Table).
Our GWAS meta-analysis of four cohorts (15,124 individuals) of Hispanic/Latino ethnicity found 9 index SNPs across 6 loci with genome-wide significant associations with QRS duration. Two loci were novel (MYOCD and SYT1), and four loci (SCN5A-SCN10A, CDKN1A, HAND1, and VTI1A) were previously identified in QRS GWAS analyses of European and African-descent individuals. This is the first GWAS of QRS duration in Hispanics/Latinos, a genetically admixed group, comprised of European, African, and Native American ancestry populations, coming from what is now Mexico, Central America, South America, and the Caribbean islands. Hispanics/Latinos were excluded in prior published QRS duration GWAS, and the genetic as well as non-genetic determinants of cardiovascular risk remain under-examined in this population.[25, 26]
We identified two novel loci associated with QRS duration among Hispanic descent individuals: MYOCD and SYT1. MYOCD encodes a nuclear protein (myocardin) expressed in cardiomyocytes and smooth muscle cell-containing tissues. MYOCD has been shown to be essential for maintaining adult heart function. Mice in which MYOCD is postnatally knocked down develop dilated cardiomyopathy and fatal heart failure. A genetic study of Dominican families found evidence that MYOCD was associated with left atrial size. Recent GWAS studies have found SNPs in MYOCD associated with PR interval duration and atrial fibrillation in European populations. The index SNP associated with QRS duration in MYOCD (rs16946539) is more common among Hispanics/Latinos (defined by the Ad Mixed American 1000 Genomes population, MAF = 0.04) than among any other 1000 Genomes super population, and is monomorphic among European- and African-descent individuals (European MAF = 0.0; Asian MAF = 0.02; African MAF = 0.0). Therefore, a QRS GWAS in Hispanics/Latinos is uniquely advantageous in uncovering this genotype-phenotype association. The finding illustrates one of the main imperatives for conducting genetic studies in diverse and under-examined populations, both for ECG traits, and for other traits. Because underlying genetic architecture can differ across racial and ethnic populations, examining new populations may uncover novel genotype-phenotype associations.
The second novel locus found in this study involves an intronic SNP in SYT1. Interestingly, a different synaptotagmin gene, SYT10, was previously associated with heart rate. The SYT1 intronic SNP was not associated with heart rate in our study. It is noteworthy that this SYT1 SNP showed no evidence of association with QRS among European and African-descent individuals. Further studies are warranted to validate this novel association in additional Hispanics/Latinos populations.
The most significant association signal was found in and surrounding two voltage-gated sodium channel genes: SCN5A and SCN10A. Whereas SCN5A is the canonical cardiac sodium channel responsible for cellular depolarization and enables conduction of the electrical signal, SCN10A appears to be particularly enriched in the specialized His Purkinje conduction fibers. Transethnic analyses intriguingly show that the regional association plot for QRS in Hispanics/Latinos more closely resembles African Americans plots than European-descent plots, with rs3922844 being the most significant SNP in the region among Hispanics/Latinos and African Americans.
The generalization study of the 28 independent index SNPs from QRS GWAS analyses in Hispanic/Latino, European, and African ancestry individuals shows remarkable consistency in the magnitude and direction of the effects overall. Although the genetic architecture of QRS duration in the three ethnic groups is largely comparable, differences are also present, such as the larger effect size at rs3922844 among Hispanics/Latinos than among European descent individuals.
Several limitations deserve consideration. First, our GWAS represents the largest performed in Hispanics/Latinos, but our sample size was nonetheless small. Additional Hispanic/Latino cohort studies are needed to extend these findings. However, novel associations were identified, and known associations were confirmed in a new ethnic population, despite the relatively small sample size. Larger sample sizes may reveal more genome-wide significant loci. For example, a SNP in the previously identified NFIA locus fell just short of genome-wide significance in Hispanics/Latinos (P = 5.1x10-8). Furthermore, while we excluded individuals with QRS durations longer than 120 ms in order to exclude individuals who have conduction defects and/or bundle branch blocks due to acquired heart disease, interesting genetic associations may be missed by this approach.
In conclusion, our findings indicate that the genetics of QRS duration are largely similar among ethnic groups. However, important differences do exist, illustrated, by the novel genome-wide significant SNP in MYOCD that is monomorphic in both Europeans and African Americans. Our study underscores the importance of conducting genetic studies in diverse and under-examined populations, such as Hispanics/Latinos, to uncover novel loci.
Materials and methods
Primary meta-analysis of individuals with Hispanic/Latino ancestry.
Our meta-analysis included 15,124 participants of self-identified Hispanic/Latino descent from the following four studies: the HCHS/SOL (n = 11,566), the Multi-Ethnic Study of Atherosclerosis (MESA, n = 1431), the Starr County Study (n = 582), and the WHI (n = 1545) (see Supplementary Material for cohort descriptions and S1 Table for baseline characteristics by cohort). Ancestry was confirmed through principal components analysis, and a small number of genetic outliers (individuals determined to be of primarily Asian ancestry) were excluded. All participants consented to the use of their genetic information for health-related research purposes.
Comparison with meta-analyses of individuals with European and African ancestry.
Comparisons of results were made between the Hispanic/Latino meta-analysis, and two published meta-analyses of QRS duration in individuals of European (n = 40,407) and African American (n = 13,301) ancestries. Details of these studies can be obtained from their original publications.[11, 18]
Participants in each of the four cohorts underwent a standard 12-lead ECG by a certified technician (see S11 Table). Participants were excluded from further analysis if they had any of the following: poor quality ECGs, atrial flutter or fibrillation, a ventricular paced rhythm, QRS duration ≥120 ms, Wolff-Parkinson-White on ECG, a history of previous myocardial infarction or heart failure, or were taking class I or class III antiarrhythmic medications.
Genotyping and imputation
HCHS/SOL participants were genotyped on an Illumina custom array that included the Illumina Omni 2.5M array (HumanOmmni2.5-8v1-1) and an additional ~150,000 SNPs. The additional SNPs were chosen to contain markers relevant to Hispanic/Latino ancestry, markers informative of Native American ethnicity, and significant loci from previous association studies. MESA, WHI, and Starr County participants were genotyped using the Affymetrix Genome-Wide Human SNP Array 6.0. SNP genotyping inclusion criteria varied slightly across studies. After individual cohort genotype QC, imputation based on the 1000 Genomes phase 1 reference panel was performed resulting in roughly 38 million SNPs (S11 Table).
Genome wide association.
To assess the association between genotype and QRS duration, individual cohort studies used additive genetic linear regression models, either in a regression model (MESA, WHI, Starr County) or a mixed model (HCHS/SOL, to account for relatedness and shared environment between individuals). The two methods estimate the same effect. Models were adjusted for age, sex, heart rate, systolic blood pressure, BMI, height, study site/region, and principal components of genetic ancestry. After we received the results from the studies, we applied an individual cohort QC filter, which excluded SNPs with low imputation quality (<0.30) or small effective sample sizes for each individual SNP (effN <30), with effN = 2 x MAF x (MAF-1) x N x Imputation Quality; where N is the number of participants. Each cohort contained between ~6M and ~20M imputed SNPs, after applying this filter.
Results were combined using fixed-effects inverse variance meta-analysis using the METAL software package, using genomic control for summary statistics to reduce test-statistic inflation. Study heterogeneity was evaluated using the Cochran Q test. Approximately 21M unique SNPs were contained in the meta-analysis. Results were considered genome-wide significant for P-values < 5x10-8. Secondary signals were identified using iterative rounds of conditional analysis, with adjustment for additional Hispanic/Latino index SNPs in the model, until there were no SNPs found to be genome-wide significant.
Transethnic generalization analysis.
Previous meta-analyses in European, East Asian, African American ancestry populations identified a total of 32 genome-wide significant SNPs. To assess whether these significant findings generalize to Hispanics/Latinos, we used the method of Sofer et al. An association is considered generalized if a significant effect in the same direction exists in both the non-Hispanic/Latino discovery population as well as the Hispanic/Latino population. This method controls the false discovery rate (FDR) of the generalization null hypotheses, and generates an r-value for each SNP (with r-values < 0.05 showing evidence that an association is generalizable under FDR control at the α = 0.05 level.)
Transethnic effect size analysis.
Comparisons of effect size differences of SNPs on QRS duration across the Hispanic/Latino, European, and African American GWAS were done using a procedure analogous to Welch’s t-tests for each of the 33 independent SNPs that were identified as having a primary or secondary independent association in any of those studies. For the purposes of Bonferroni correction, there were 29 independent SNPs available for testing in all 3 cohorts. Some SNPs were not available in all cohorts due to use of different imputation panels. Comparisons for 29 SNPs among 3 studies resulted in 87 tests. Therefore, differences in effect size were determined to be significant when P<5.75E-04.
Cross phenotype analysis.
Index SNPs discovered in the QRS duration analysis were also examined for associations with other ECG phenotypes, including QT, PR, heart rate, and SDNN. These GWAS efforts were based upon the same underlying Hispanic/Latino cohorts as the QRS duration GWAS. However, due to different inclusion/exclusion criteria, differences in the study samples do exist between studies. Full details of these studies can be obtained from their original publications.[21–23] Significance for these other traits exceeded either: a genome-wide significance threshold (P<5.0E-08); Bonferroni corrected significance (P<1.39E-03 for 36 tests); or nominal significance (P<0.05).
The HaploReg v4.1 online web resource was used to functionally annotate genome-wide significant SNPs. HaploReg utilizes data obtained from the ENCODE and RoadMap projects, to give information on how SNPs might alter gene expression in diverse tissue types. We restricted our analysis to only specific heart tissues—namely, fetal heart tissue, the right atrium, the right ventricle, and the left ventricle. Based on the chromatin-15 state model, we summarized the potential function of SNPs in the genome-wide significant loci in each of the different heart tissues. For each loci, we examined primary SNPs, secondary signal SNPs, and all other SNPs in high LD (r2>0.80) with these SNPs. The LD structure pattern used for this analysis was the 1000 Genomes AMR Phase-1 super-population.
S1 Fig. QQ plot of Hispanic/Latino QRS duration GWAS meta-analysis.
S3 Fig. Forest plots showing 95% confidence intervals of the effect size of each Hispanic/Latino index SNP on QRS duration in milliseconds across each contributing study and the combined meta-analysis.
S4 Fig. Regional association plots showing all results in the European, Hispanic/Latino, and African American QRS duration GWAS surrounding each of the Hispanic/Latino significant loci.
Plots created with LocusZoom software. The index SNP in each figure is labeled and colored purple. All other SNPs in the region are plotted at their significance levels. The color of each SNP corresponds to the linkage disequilibrium (r2) between the plotted SNP and the index SNP.
S5 Fig. Regional association plots for the HCHS/SOL cohort for each of the index SNPs which was imputed rather than being directly genotyped in the cohort.
Plots created with LocusZoom software. Each plot shows all GWAS results surrounding the index SNP. The index SNP in each figure is labeled and colored purple. All other SNPs in the region are plotted at their significance levels. The color of each SNP corresponds to the linkage disequilibrium (r2) between the plotted SNP and the index SNP. SNPs plotted as circles were directly genotyped, and SNPs plotted as X’s were imputed.
S1 Table. Participant characteristics from the studies contributing to the meta-analysis.
S2 Table. Heterogeneity tests for index SNPs across the participating cohorts.
S3 Table. Summary of genetic imputation of index SNPs across the participating cohorts.
S4 Table. Coded allele frequencies for index SNPs significantly associated with QRS duration among participants of Hispanic/Latino ancestry (n = 15,124).
S5 Table. Index SNPs in Hispanic/Latino QRS duration GWAS (n = 15,124) and corresponding SNPs in the European QRS duration GWAS (n = 40,407).
S6 Table. Index SNPs in Hispanic/Latino QRS duration GWAS (n = 15,124) and corresponding SNPs in the African American QRS duration GWAS (n = 13,301).
S7 Table. Significant results for Welch’s t-tests of differences in effect sizes at Hispanic/Latino index SNPs across Hispanic/Latino, European, and African American GWAS results.
S8 Table. Generalization of the associations in Hispanic/Latino QRS duration GWAS meta-analysis (n = 15,124) for previously discovered loci from QRS duration GWAS among European (n = 40,407), African American, (n = 13,301), and East Asian (n = 6805) populations, and a European-African America meta-analysis (n = 53,708).
S9 Table. Associations of QRS duration index SNPs with other ECG phenotypes (QT duration, PR duration, Heart Rate, and Heart Rate Variability) in the same Hispanic/Latino study population.
S10 Table. Summary of functional annotations in heart tissues for QRS duration significant loci in the HaploReg v4.1 database.
S11 Table. ECG and genotype measurement methods for the participating cohorts.
We acknowledge the work of the CHARGE QRS GWAS Consortium and the CARe-COGENT African-American QRS Consortium for their work on the respective European and African American GWAS studies referenced here. Full membership for these two groups is provided in S1 Appendix.
Hispanic Community Health Study/Study of Latinos (HCHS/SOL): We thank the participants and staff of the HCHS/SOL study for their contributions to this study.
Multi-Ethnic Study of Atherosclerosis (MESA): We also thank the other investigators, the staff, and the participants of MESA for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.
Starr County Study: We thank the field staff in Starr County for collection of these data and are grateful to the study participants who gave their time and contributed to the study. Genotyping services were provided by the Center for Inherited Disease Research (CIDR).
Women’s Health Initiative: We thank the study participants and staff for contributions to the study. All contributors to WHI science are listed at https://www.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20Investigator%20Long%20List.pdf.
- 1. Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. The American Journal of Cardiology. 2004;93(2):244–6. pmid:14715361
- 2. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN, Failure DoVASToATiCH. QRS duration and mortality in patients with congestive heart failure. American Heart Journal. 2002;143(6):1085–91. pmid:12075267
- 3. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92(2):231–7. pmid:7600655
- 4. Desai AD, Yaw TS, Yamazaki T, Kaykha A, Chun S, Froelicher VF. Prognostic significance of quantitative QRS duration. The American Journal of Medicine. 2006;119(7):600–6. pmid:16828632
- 5. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine. 2009;361(14):1329–38. pmid:19723701
- 6. Russell MW, Law I, Sholinsky P, Fabsitz RR. Heritability of ECG measurements in adult male twins. Journal of Electrocardiology. 1998;30:64–8. pmid:9535482
- 7. Havlik RJ, Garrison RJ, Fabsitz R, Feinleib M. Variability of heart rate, PR, QRS and QT durations in twins. Journal of Electrocardiology. 1980;13(1):45–8. pmid:7188949
- 8. Li J, Huo Y, Zhang Y, Fang Z, Yang J, Zang T, et al. Familial aggregation and heritability of electrocardiographic intervals and heart rate in a rural Chinese population. Annals of Noninvasive Electrocardiology. 2009;14(2):147–52. pmid:19419399
- 9. Mutikainen S, Ortega‐Alonso A, Alén M, Kaprio J, Karjalainen J, Rantanen T, et al. Genetic influences on resting electrocardiographic variables in older women: a twin study. Annals of Noninvasive Electrocardiology. 2009;14(1):57–64. pmid:19149794
- 10. Ritchie MD, Denny JC, Zuvich RL, Crawford DC, Schildcrout JS, Bastarache L, et al. Genome-and phenome-wide analysis of cardiac conduction identifies markers of arrhythmia risk. Circulation. 2013;127:1377–85. pmid:23463857
- 11. Sotoodehnia N, Isaacs A, de Bakker PI, Dörr M, Newton-Cheh C, Nolte IM, et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nature Genetics. 2010;42(12):1068–76. pmid:21076409
- 12. Holm H, Gudbjartsson DF, Arnar DO, Thorleifsson G, Thorgeirsson G, Stefansdottir H, et al. Several common variants modulate heart rate, PR interval and QRS duration. Nature Genetics. 2010;42(2):117–22. pmid:20062063
- 13. Hong K-W, Lim JE, Kim JW, Tabara Y, Ueshima H, Miki T, et al. Identification of three novel genetic variations associated with electrocardiographic traits (QRS duration and PR interval) in East Asians. Human Molecular Genetics. 2014;23(24):6659–67. pmid:25035420
- 14. Chambers JC, Zhao J, Terracciano CM, Bezzina CR, Zhang W, Kaba R, et al. Genetic variation in SCN10A influences cardiac conduction. Nature Genetics. 2010;42(2):149–52. pmid:20062061
- 15. Sano M, Kamitsuji S, Kamatani N, Hong K-W, Han B-G, Kim Y, et al. Genome-wide association study of electrocardiographic parameters identifies a new association for PR interval and confirms previously reported associations. Human molecular genetics. 2014;23(24):6668–76. pmid:25055868
- 16. Smith JG, Lowe JK, Kovvali S, Maller JB, Salit J, Daly MJ, et al. Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae. Heart Rhythm. 2009;6(5):634–41. pmid:19389651
- 17. Jeff JM, Ritchie MD, Denny JC, Kho AN, Ramirez AH, Crosslin D, et al. Generalization of Variants Identified by Genome‐Wide Association Studies for Electrocardiographic Traits in African Americans. Annals of Human Genetics. 2013;77(4):321–32. pmid:23534349
- 18. Evans DS, Avery CL, Nalls MA, Li G, Barnard J, Smith EN, et al. Fine-mapping, novel loci identification, and SNP association transferability in a genome-wide association study of QRS duration in African Americans. Human Molecular Genetics. 2016:;ddw284.
- 19. Pruitt KD, Tatusova T, Maglott DR. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic acids research. 2006;35(suppl_1):D61–D5.
- 20. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26(18):2336–7. pmid:20634204
- 21. Méndez-Giráldez R, Gogarten SM, Below JE, Yao J, Seyerle AA, Highland HM, et al. GWAS of the electrocardiographic QT interval in Hispanics/Latinos generalizes previously identified loci and identifies population-specific signals. Scientific Reports. 2017;7(1):17075. pmid:29213071
- 22. Seyerle AA, Lin HJ, Gogarten SM, Stilp A, Giráldez RM, Soliman E, et al. Genome-wide association study of PR interval in Hispanics/Latinos identifies novel locus at ID2. Heart. 2018;104(11):904–11. pmid:29127183
- 23. Kerr KF, Avery CL, Lin HJ, Raffield LM, Zhang QS, Browning BL, et al. Genome-wide association study of heart rate and its variability in Hispanic/Latino cohorts. Heart Rhythm. 2017;14(11):1675–84. pmid:28610988
- 24. Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Research. 2016;44(D1):D877–D81. pmid:26657631
- 25. Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nature. 2016;538(7624):161. pmid:27734877
- 26. Conomos MP, Laurie CA, Stilp AM, Gogarten SM, McHugh CP, Nelson SC, et al. Genetic diversity and association studies in US Hispanic/Latino populations: applications in the Hispanic Community Health Study/Study of Latinos. The American Journal of Human Genetics. 2016;98(1):165–84. pmid:26748518
- 27. Mikhailov AT, Torrado M. Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease. Heart Failure Reviews. 2016;21(6):783–94. pmid:27306370
- 28. Huang J, Lu MM, Cheng L, Yuan L-J, Zhu X, Stout AL, et al. Myocardin is required for cardiomyocyte survival and maintenance of heart function. Proceedings of the National Academy of Sciences. 2009;106(44):18734–9.
- 29. Wang L, Di Tullio MR, Beecham A, Slifer S, Rundek T, Homma S, et al. A comprehensive genetic study on left atrium size in Caribbean Hispanics identifies potential candidate genes in 17p10. Circulation: Cardiovascular Genetics. 2010;3(4):386–92. pmid:20562446
- 30. van Setten J, Brody JA, Jamshidi Y, Swenson BR, Butler AM, Campbell H, et al. PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity. Nature Communications. 2018;9(1):2904. pmid:30046033
- 31. Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nature Genetics. 2018;50(9):1234–9. pmid:30061737
- 32. Den Hoed M, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, et al. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nature Genetics. 2013;45(6):621–31. pmid:23583979
- 33. Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3: Genes, Genomes, Genetics. 2011;1(6):457–70.
- 34. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190–1. pmid:20616382
- 35. Sofer T, Heller R, Bogomolov M, Avery CL, Graff M, NK E., et al. A powerful statistical framework for generalization testing in GWAS, with application to the HCHS/SOL. Genetic Epidemiology. 2017;41(3):251–8. pmid:28090672
- 36. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57. pmid:22955616
- 37. Romanoski CE, Glass CK, Stunnenberg HG, Wilson L, Almouzni G. Epigenomics: Roadmap for regulation. Nature. 2015;518(7539):314–6. pmid:25693562